Sunrakshakk Industries: Q1 FY27 signals a faster FMCG pivot, but input costs remain the swing factor
Sunrakshakk Industries India Limited, formerly A.K. Spintex, reported its strongest quarter so far in Q1 FY27. Consolidated revenue from operations rose to 276.33 crore, up 120.64% year on year and 39.85% sequentially. EBITDA grew to 22.59 crore and PAT to 15.04 crore, with PAT margin improving to 5.44% from 5.21% in Q1 FY26. The quarter reinforced what has been the company’s defining narrative over the last few years: a transition from a textile-led base to an FMCG, FMCG intermediates, and edibles-driven manufacturing platform.
Management attributed the growth to broad-based demand across FMCG, intermediates, and edibles, plus the benefit of capacity additions and ramp-ups across Roorkee, Bhilwara, and Guwahati. At the same time, the quarter also highlighted a key operational variable that investors will continue to watch. Consolidated EBITDA margin moderated to 8.18% versus 10.19% in Q4 FY26, which management linked to higher raw material costs amid geopolitical headwinds and crude-linked volatility.
A quarter that reflects the new revenue mix
Sunrakshakk’s commentary and disclosures suggest the FMCG pivot is no longer an early experiment. In the management quote included in the presentation, the company stated that FMCG, FMCG intermediates and edibles together contribute about 90.6% of consolidated revenue in Q1 FY27. The revenue mix slide separately shows Q1 FY27 revenue of 276.33 crore with FMCG at 250.10 crore and textiles at 26.23 crore.
The company’s operating footprint supports this shift. It disclosed five FMCG plants and one fabric plant, a customer base of over 200, and an aggregate FMCG plus FMCG intermediates capacity of 20,840 tons per month. On textiles, it disclosed processing capacity of 45 lakh meters per month and historical processed volumes of 5.10 crore meters in FY25-26.
The financial progression is backed by the historical P and L disclosed in the deck. FY26 revenue was 607.75 crore versus 180.16 crore in FY25, while FY26 PAT increased to 34.98 crore from 11.01 crore.
Facility-level performance adds transparency to the scale-up
One of the more useful elements of the presentation is the revenue breakup by location and section for Q1 FY27 versus Q4 FY26. This is not a full segment result in the accounting sense, but it offers tangible evidence of where growth is coming from.
Roorkee’s noodle section, which aligns with soap noodle activity under intermediates, rose to 87.62 crore in Q1 FY27 from 44.47 crore in Q4 FY26. Roorkee’s soap section rose to 27.50 crore from 17.63 crore. Bhilwara’s home care and detergent revenue increased to 40.98 crore from 32.50 crore, while its edibles contribution remained relatively steady at 30.34 crore versus 29.26 crore. Guwahati’s cosmetics increased to 26.15 crore from 20.91 crore, and Guwahati’s noodle section rose to 37.75 crore from 26.01 crore.
Management linked this progression to capacity commissioning and customer additions over recent quarters. During the concall, it highlighted that the company had invested significantly in manufacturing facility acquisitions and capacity additions over the last two to three quarters, which is now reflecting in revenue.
Margin trajectory: operating leverage versus crude-linked volatility
The company’s key debate in Q1 FY27 was not growth but margin volatility. Consolidated EBITDA margin moved down to 8.18% in Q1 FY27 from 10.19% in Q4 FY26. Management attributed this to higher raw material costs amid geopolitical tension and crude-linked derivatives price volatility, affecting input costs, packaging and supply chain planning.
The transcript provided more color. It cited higher dyes, chemicals, consumables, and boiler fuel as key cost drivers, and also noted that some chemicals such as LABSA have pricing linked to international markets. The company said the textile business was impacted more significantly because it could not increase prices in that segment in the last quarter, and it expects normalization by Q3 or Q4, although Q2 is also seeing the impact.
Despite the consolidated pressure, management stated that the FMCG segment EBITDA margin improved to 8.55% from 7.90% in Q1 FY26. This indicates that, at least for the FMCG operations, operating leverage is beginning to show through, even as the consolidated mix and cost pressures can create quarter-to-quarter swings.
Capacity additions are largely done, utilization is the lever
A central operational update in Q1 FY27 was the commissioning of a new soap production line at Roorkee, adding about 1,700 MT of monthly capacity. This took total FMCG plus FMCG intermediary capacity to 20,840 tons per month, up from 19,640 tons per month as of Q4 FY26.
Management also provided a clear utilization datapoint: current capacity utilization is around 50% to 55% because recently added capacities are yet to be fully utilized. It added that for the next one to one-and-a-half years it does not expect much incremental capex for capacity addition. In edibles, it stated the Bhilwara plant is currently operating only one shift, with the second shift available, which provides headroom for output growth without immediate capacity build.
This framing supports the company’s medium-term revenue aspiration. In the concall, management reiterated the goal of about 1,000 crore revenue by FY28, and then went further by stating that for FY26-27 it expects to close between 900 crore and 1,000 crore revenue, with 15% to 20% growth in FY27-28. It also discussed profitability expectations of around 6% for the current year with an improvement of 0.75% to 1% in FY28.
Capital allocation: clarifications and a return framing
The deck includes a capital allocation slide that attempts to connect deployed capital and outcomes. It states 98.65 crore was raised for the FMCG pivot and highlights an implied return on capital of about 28% to 30% on a run-rate basis, along with a before versus after revenue and PAT comparison.
The concall includes an important clarification on the fundraise. Management stated that the 98.65 crore fundraise was not used to acquire Sunrakshakk Agro Products Pvt. Ltd., because that acquisition occurred prior to fundraising. It stated the funds were majorly utilized to acquire the food manufacturing facility in Bhilwara and the soap noodle and cosmetic manufacturing facility in Guwahati.
Management also said there is no plan for additional fundraising at present. It emphasized a focus on prudent capital allocation and efficient utilization of raised funds, with working capital expected to rise with business growth but with an intent to optimize so that working capital does not increase in line with revenue proportionally.
The bigger picture: where incremental growth is expected
In the Q and A, management indicated that over the next two years, incremental revenue is expected to be higher from the food business and the soap segment. It also suggested the long-term revenue mix could evolve to textiles contributing around 8% to 10% of revenue, with the balance coming from the FMCG segment.
Another point that stands out is the company’s current go-to-market model. When asked about the revenue mix between B2B manufacturing and own brand products, management stated that as of now, revenue is basically B2B and the company is not in B2C.
Takeaways from Q1 FY27
Sunrakshakk’s Q1 FY27 numbers show that the FMCG pivot is translating into measurable scale and profitability. Consolidated revenue of 276.33 crore and PAT of 15.04 crore represent a step-change versus the previous year, and facility-level revenue disclosures provide additional comfort that growth is broad-based across Roorkee, Bhilwara and Guwahati.
The near-term variable is margins. Management has clearly linked recent margin pressure to crude-linked input volatility and expects normalization over the next couple of quarters. With utilization at 50% to 55%, the company’s next phase appears to be more about ramping existing capacities than adding new ones. If costs stabilize and utilization rises as management expects, the medium-term revenue aspiration of about 1,000 crore by FY28 is framed as achievable within existing capacity, as stated in the concall.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
